Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 21, Issue 1, 2014, Pages 43-50

  Tanaka, Atsushi ^a   Tazuma, Susumu ^b   Okazaki, Kazuichi ^c   Tsubouchi, Hirohito ^d   Inui, Kazuo ^e   Takikawa, Hajime ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

^e FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

Author keywords

Autoimmune pancreatitis; Inflammatory bowel diseases; Nationwide survey; Prednisolone; Ursodeoxycholic acid

Indexed keywords

BEZAFIBRATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; PREDNISOLONE; SERUM ALBUMIN; URSODEOXYCHOLIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HEALTH SURVEY; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOGLOBULIN G4 SCLEROSING CHOLANGITIS; INFLAMMATORY BOWEL DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PANCREAS DISEASE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; QUESTIONNAIRE; AGED; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; CLINICAL TRIAL; COMPLICATION; IMMUNOLOGY; MULTICENTER STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; AUTOIMMUNE DISEASES; CHOLANGITIS, SCLEROSING; FEMALE; HUMANS; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES;

EID: 84897094632     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1002/jhbp.50     Document Type: Article

References (29)

1. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013; doi: 10.1016/S0140-6736 (13)60096-3.
2. Karlsen TH, Boberg KM. Update on primary sclerosing cholangitis. J Hepatol. 2013;59:571-82.
3. Molodecky NA, Kareemi H, Parab R, Barkema HW, Quan H, Myers RP, et al. Incidence of primary sclerosing cholangitis: A systematic review and meta-analysis. Hepatology. 2011;53: 1590-9.
4. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan-analysis of 192 cases. J Gastroenterol. 1997;32:134-7.
5. Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. Hepatol Res. 2004;29:153-9.
6. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut. 1996; 38:610-15.
7. Farrant J, Hayllar K, Wilkinson M, Karani J, Portmann B, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Ganstroenterology. 1991;100: 1710-17.
8. Schrumpf E, Abdelnoor M, Fausa O, Elgjo K, Jenssen E, Kolmannskog F. Risk factors in primary sclerosing cholangitis. J Hepatol. 1994;21:1061-6.
9. Wiesner R, Grambsch P, Dickson E, Ludwig J, MacCarty R, Hunter EB, et al. Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis. Hepatology. 1989;10: 430-6.
10. Hamano H, Kawa S, Uehara T, Ochi Y, Takayama M, Komatsu K, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: Part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc. 2005;62:152-7.
11. Uehara T, Hamano H, Kawa S, Sano K, Honda T, Ota H. Distinct clinicopathological entity "autoimmune pancreatitis-associated sclerosing cholangitis". Pathol Int. 2005;55:405-11.
12. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: Do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol. 2004;28:1193-203.
13. Hamano H, Umemura T, Uehara T, Kawa S, Kiyosawa K. IgG4-related sclerosing cholangitis should be included as an exclusion criterion for the diagnosis of primary sclerosing cholangitis. Am J Gastroenterol. 2007;102:691-2.
14. Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536-42.
15. Tanaka A, Tazuma S, Okazaki K, Tsubouchi H, Inui K, Takikawa H. A nation-wide survey of sclerosing cholangitis. Tando. 2013;27:176-87 (in Japanese with English abstract).
16. Lindor K, LaRusso N. Primary sclerosing cholangitis. In: Schiff E, editor. Schiff's disease of the liver, 10th edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2007. p. 673-84.
17. Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229.
18. Kaplan G, Laupland K, Butzner D, Urbanski S, Lee S. The burden of large and small duct primary sclerosing cholangitis in adults and children: A population-based analysis. Am J Gastroenterol. 2007;102:1042-9.
19. Tanaka A. The epidemiological study of PSC in Japan. Health Labour Sciences Research Grant from Research on Measures for Intractable Diseases, the intractable hepato-biliary disease study group in Japan. 2008 [in Japanese].
20. Tanaka A, Takikawa H. Geoepidemiology of primary sclerosing cholangitis: A critical review. J Autoimmun. 2013; doi: 10.1016/j.jaut.2013.07.005.
21. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology. 2003;125:1364-9.
22. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol. 1998;33:99-103.
23. Boonstra K, Weersma RK, van Erpecum KJ, Rauws EA, Spanier BW, Poen AC, et al. Population-based epidemiology, malignancy risk and outcome of primary sclerosing cholangitis. Hepatology. 2013; doi: 10.1002/hep.26565.
24. Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: A population-based cohort study. J Hepatol. 2008;48:939-44.
25. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol. 1994;21:787-91.
26. Kingham JG, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology. 2004;126:1929-30.
27. Lindkvist B, Benito de Valle M, Gullberg B, Bjornsson E. Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden. Hepatology. 2010;52: 571-7.
28. Ang TL, Fock KM, Ng TM, Teo EK, Chua TS, Tan JY. Clinical profile of primary sclerosing cholangitis in Singapore. J Gastroenterol Hepatol. 2002;17:908-13.
29. Ghazale A, Chari ST, Zhang L, Smyrk TC, Takahashi N, Levy MJ, et al. Immunoglobulin G4-associated cholangitis: Clinical profile and response to therapy. Gastroenterology. 2008;134:706-15.